(Q58960862)

English

HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/uL): an analysis of 338 clinical events from a randomized clinical trial*

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Clementina Maria Galluzzo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Maria F. Pirillo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Mauro Andreotti

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

V Fragola

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Giannini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

C Tomino

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

75-84

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

AIDS across Europe, 1994-98: the EuroSIDA study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Effect of highly active antiretroviral therapy on the incidence of HIV-related cytomegalovirus retinitis and retinal detachment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Discontinuation of Secondary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis againstPneumocystis cariniiPneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Relations among CD4 Lymphocyte Count Nadir, Antiretroviral Therapy, and HIV-1 Disease Progression: Results from the EuroSIDA Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00104.X

21 January 2018

Identifiers

10.1046/J.1468-1293.2002.00104.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12010353%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58960862&oldid=1070563705"